Prot#282-CC-207: Evaluation of Efficacy, Safety and Tolerability of NGM282 (Aldafermin) in a Phase 2b, Randomized, Doubleblind, Placebo-controlled, Multi-center Study in Subjects with Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (ALPINE 4)

  • VanWagner, Lisa Beth (PD/PI)
  • Rinella, Mary Eugenia (Other)

Project: Research project

Project Details

StatusActive
Effective start/end date12/22/20 → 12/22/23

Funding

  • Medpace Clinical Research LLC (Prot#282-CC-207)
  • NGM Biopharmaceuticals, Inc. (Prot#282-CC-207)